Effer-K and Inotuzumab ozogamicin Intravenous
Determining the interaction of Effer-K and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: potassium bicarbonate / potassium citrate
Brand name: Effer-K, K-Effervescent, K-Prime, K-vescent, Klor-Con/EF, Effervescent Potassium, K-vescent, K+Care ET
Synonyms: Potassium Bicarbonate and Potassium Citrate
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Effer-K-Inova
- Effer-K-Inova 4/1 topical
- Effer-K-Inova 8/2 topical
- Effer-K-Inova ACT
- Effer-K-Inrebic
- Effer-K-Inspra
- Inotuzumab ozogamicin Intravenous-Effer-K Tablets
- Inotuzumab ozogamicin Intravenous-Effervescent Potassium
- Inotuzumab ozogamicin Intravenous-Effervescent Potassium/Chloride
- Inotuzumab ozogamicin Intravenous-Effexor
- Inotuzumab ozogamicin Intravenous-Effexor XR
- Inotuzumab ozogamicin Intravenous-Effexor XR (Venlafaxine Extended-Release Capsules)